361
Participants
Start Date
June 30, 2004
Primary Completion Date
October 31, 2005
Study Completion Date
October 31, 2005
ARV regimen
As prescribed
enfuvirtide [Fuzeon]
90mg sc bid for 12 weeks
New York
New York
Staten Island
Mount Vernon
Manhasset
Rochester
Harrisburg
Philadelphia
Reading
West Reading
Washington D.C.
Silver Spring
Fairfax
Hampton
Winston-Salem
Columbia
Charleston
Decatur
Lawrenceville
Atlanta
Atlanta
Atlanta
Atlanta
Atlanta
Atlanta
Daytona Beach
Jacksonville
Jacksonville
Tallahassee
Orlando
Vero Beach
Pompano Beach
Miami
Miami Beach
Miami Beach
South Miami
Fort Lauderdale
Fort Lauderdale
Plantation
Tamarac
Fort Lauderdale
Oakland Park
North Palm Beach
Boynton Beach
Brandon
Tampa
Tampa
Bay Pines
Fort Myers
Sarasota
Port Saint Lucie
Louisville
Akron
Cincinnati
Ypsilanti
Minneapolis
Butte
Chicago
Springfield
St Louis
St Louis
St Louis
Kansas City
Kansas City
Topeka
Wichita
Dallas
Dallas
Fort Worth
Houston
Houston
Houston
Galveston
San Antonio
Austin
Boise
Phoenix
Las Vegas
Los Angeles
Los Angeles
Los Angeles
Tarzana
Palm Springs
Rancho Mirage
Bakersfield
San Mateo
Oakland
Berkeley
Modesto
Seattle
Seattle
Berkley
East Orange
Englewood
Jersey City
Newark
Newark
Newark
Perth Amboy
Somers Point
West Orange
Stony Brook
Portland
Cagaus
Ponce
San Juan
Hoffmann-La Roche
INDUSTRY